Merck & Co. has agreed to acquire Cidara Therapeutics for approximately $9.2 billion, the companies said, in a deal designed to bolster the buyer’s antiviral portfolio with a Phase III drug designed ...
Prophylactic HPV vaccines prevent infection but not existing disease. A nasal nanogel vaccine shows preclinical promise for ...
Objective To assess the effects of behaviourally informed short message service (SMS) reminders on demand for human ...
A young mother has hit out at the NHS after she was denied a smear test because of her age-despite heavy bleeding and family ...
Cervical cancer, which affects the reproductive tract, is one of the most common cancers in women worldwide. It is primarily ...
Cervical cancer, which affects the reproductive tract, is one of the most common cancers in women worldwide. It is primarily ...
The Head and Neck Cancer Drugs/Therapeutics Market is experiencing substantial growth, valued at USD 4.2 Billion in 2024 and projected to reach USD 8.5 Billion by 2033. This expansion reflects ...
Dar es Salaam. Less than five percent of female sex workers get screened for cervical cancer, despite being among the groups most vulnerable to the disease, new research reveals.The study, titled ...
The campaign, which will run until December 27 in the municipalities, is already showing significant progress. Matanzas has ...
A nanoparticle vaccine designed to fight cancers induced by human papillomavirus (HPV) eradicated tumors in an animal model ...
A nationwide study in Scotland confirms that HPV vaccination provides strong, lasting protection against cervical precancer ...
A common type of human papillomavirus (HPV) could be more dangerous than we thought. The virus, known as beta-HPV, was ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback